In Reply to Dr. Herrera et al
H Ishikawa, T Ohno, S Kato, M Wakatsuki… - International Journal of …, 2007 - redjournal.org
To the Editor: We appreciate helpful comments provided by Dr. Herrera and colleagues on
our article. We would like to discuss the results of two recent phase I/II studies (1, 2) of …
our article. We would like to discuss the results of two recent phase I/II studies (1, 2) of …
In Response to Dr. Wei and Colleagues
P Georg, R Pötter, D Georg, C Kirisits… - International Journal of …, 2011 - redjournal.org
To the Editor: We read the paper wrote by Georg (1) and very interested in their work(1–3).
Their data and experience are valuable for promoting the usage of image-guided …
Their data and experience are valuable for promoting the usage of image-guided …
In Regard to Georg et al
A Sharma, DN Sharma, GK Rath - International Journal of Radiation …, 2013 - redjournal.org
In Regard to Georg et al Page 1 Thomas Jefferson University Philadelphia, Pennsylvania
http://dx.doi.org/10.1016/j.ijrobp.2012.05.037 References 1. Shen X, Keith SW, Mishra MV, et al …
http://dx.doi.org/10.1016/j.ijrobp.2012.05.037 References 1. Shen X, Keith SW, Mishra MV, et al …
A Phase II study of acute toxicity for Celebrex™(celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG …
DK Gaffney, K Winter, AP Dicker, B Miller… - International Journal of …, 2007 - Elsevier
Purpose: To determine treatment-related acute toxicity rates in patients with locally
advanced cervical cancer treated by oral celecoxib, iv cisplatin and 5-FU, and concurrent …
advanced cervical cancer treated by oral celecoxib, iv cisplatin and 5-FU, and concurrent …
In response to Drs. Krause, Baumann, and Thames
B Solomon, C Cullinane, GA McArthur - International Journal of …, 2003 - redjournal.org
To the Editor: We thank Drs. Krause, Baumann, and Thames for their letter, in which they
compare the results of their study of the epidermal growth factor receptor (EGFR) tyrosine …
compare the results of their study of the epidermal growth factor receptor (EGFR) tyrosine …
A Phase I–II Study of COX-2 Inhibitor, Celebrex (Celecoxib) and Chemoradiation in Patients With Locally Advanced Cervical Cancer: Primary Endpoint Analysis of …
DK Gaffney, K Winter, A Dicker, B Miller… - International Journal of …, 2005 - redjournal.org
Purpose/Objective: To determine treatment related toxicity rates in patients with locally
advanced cervical cancer treated by oral celecoxib, intravenous cisplatin and 5-FU, and …
advanced cervical cancer treated by oral celecoxib, intravenous cisplatin and 5-FU, and …
In regard to Dr. Vasanthan et al.(Int J Radiat Oncol Biol Phys 2005; 61: 145–153)
J van der Zee, GC van Rhoon, P Wust - International journal of …, 2005 - redjournal.org
To the Editor: We have read with great interest the report by Vasanthan et al. on a Phase III
study investigating the addition of hyperthermia to radiotherapy in patients with cervix cancer …
study investigating the addition of hyperthermia to radiotherapy in patients with cervix cancer …
[引用][C] Letter to the Editor by K. Serkies, J. Jassem on Á. Mayer, et al. Primary Radiotherapy of Stage IIA/B–IIIB Cervical Carcinoma. A Comparison of Continuous …
K Serkies - Strahlentherapie und Onkologie, 2005 - Springer
We read with interest the article by Mayer et al.[2]. The authors compared the efficacy of two
regimens in 210 stage IIA− IIIB cervical cancer patients: sequential radiation therapy (SRT) …
regimens in 210 stage IIA− IIIB cervical cancer patients: sequential radiation therapy (SRT) …
In regard to Solomon et al.: EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 …
To the Editor: We thank Drs. Krause, Baumann, and Thames for their letter, in which they
compare the results of their study of the epidermal growth factor receptor (EGFR) tyrosine …
compare the results of their study of the epidermal growth factor receptor (EGFR) tyrosine …
[PDF][PDF] Author Disclosure: DL Rash: None. YC Lee: None. M. Mathai: None. RL Stern: None. R. Valicenti: None. J. Mayadev: None.
AK Gandhi, GK Rath, DN Sharma, V Subramani… - researchgate.net
Purpose/Objective (s): To compare acute gastrointestinal (GI) and genitourinary (GU)
toxicities in locally advanced carcinoma cervix treated with conventional radiation therapy …
toxicities in locally advanced carcinoma cervix treated with conventional radiation therapy …